Unpublished conference/Abstract (Scientific congresses and symposiums)
Real-World Outcomes of Belgian Patients with Newly Diagnosed Acute Myeloid Leukaemia Treated with Venetoclax and Azacitidine: A Multicentre Chart Review Study
Maertens, johan; Van Obbergh Florence; De Voeght, Adrienet al.
2025 • 40th General Annual Meeting of the Belgian Hematology Society 2025
[en] The aim of this study was to generate real-world evidence (RWE) of the outcomes of Belgian patients with newly diagnosed acute myeloid leukaemia (AML) who were treated with venetoclax and azacitidine (VenAZA).
Disciplines :
Hematology
Author, co-author :
Maertens, johan; KULeuven > Clinical hematology
Van Obbergh Florence
De Voeght, Adrien ; Université de Liège - ULiège > GIGA ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Real-World Outcomes of Belgian Patients with Newly Diagnosed Acute Myeloid Leukaemia Treated with Venetoclax and Azacitidine: A Multicentre Chart Review Study
Publication date :
2025
Event name :
40th General Annual Meeting of the Belgian Hematology Society 2025
